Susan Halabi

Duke University

United States

Research Interests

Explore related searches

Professors in United States Professors in Cancer Biology Cancer Biology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (10)

Andrew Armstrong

Professor

Duke Cancer Institute

UNITED STATES

View details

Richard D Riley

Professor of Biostatistics

University of Birmingham

UNITED KINGDOM

View details

AKASH ROY

Medical University of South Carolina

UNITED STATES

View details

Kim Chi

Chief Medical Officer

BC Cancer

CANADA

View details

Nicholas Turner

Assistant Professor

Duke University School of Medicine

UNITED STATES

View details

Emmanuel Stylianos Antonarakis

Professor of Medicine, Associate Director for Translation

UNITED STATES

View details

Roland Matsouaka

Assistant Professor

Duke University

UNITED STATES

View details

Funda Meric-Bernstam

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Andrew Nixon

Duke University Medical Center

UNITED STATES

View details

Huiman Barnhart

Professor

Duke University

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Susan Halabi

Research Interests

Explore related searches

Contact this professor

Articles (20)

Statistical Perspectives and Meta-Analytic Approaches in Surrogate End Point Evaluation for Chronic Lymphocytic Leukemia

Sample Size and Power Calculations With Win Measures Based on Hierarchical Endpoints

Sample Size for Enriched Biomarker Designs With Measurement Error for Time‐to‐Event Outcomes

Incorporating data from multiple ongoing trials for Bayesian two-stage phase II single-arm studies

Design aspects for prognostic factor studies

Pathogenic Genomic Alterations in Circulating Tumor DNA Predict Overall Survival in Men with Metastatic Castrate-resistant Prostate Cancer

How To Interpret Subgroup Analyses from Prospective Randomized Clinical Trials: What Clinicians Need To Know

Updated 5-year results for short course abiraterone acetate and LHRH agonist for unfavorable intermediate and favorable high-risk prostate cancer

Variable Selection for Multivariate Failure Time Data via Regularized Sparse-Input Neural Network

Factors Affecting Genomic Testing in Prostate Cancer: Results From the Decision-Making, Experience, and Confidence In Determining Genomic Evaluation (DECIDE) Survey

PSMA-positive Circulating Tumor Cell Detection and Outcomes with Abiraterone or Enzalutamide Treatment in Men with Metastatic Castrate-resistant Prostate Cancer

External Validation of a Prognostic Model of Overall Survival in Men With Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer

Randomized Phase II Multicenter Trial of Abiraterone Acetate With or Without Cabazitaxel in the Treatment of Metastatic Castration-Resistant Prostate Cancer

Olaparib in Patients With Metastatic Prostate Cancer With BRCA1/2 Mutation: Results From the TAPUR Study

Landscape of coronavirus disease 2019 clinical trials: New frontiers and challenges.

Pertuzumab Plus Trastuzumab in Patients With Colorectal Cancer With ERBB2 Amplification or ERBB2/3 Mutations: Results From the TAPUR Study

Penalized weighted proportional hazards model for robust variable selection and outlier detection

Predictive Biomarkers of Overall Survival in Patients with Metastatic Renal Cell Carcinoma Treated with IFNα ± Bevacizumab: Results from CALGB 90206 (Alliance)

Comparison of regression imputation methods of baseline covariates that predict survival outcomes

Sarcomatoid Renal Cell Carcinoma: An Immune Checkpoint–responsive Subset?

Collaborators (10)

Andrew Armstrong

Richard D Riley

AKASH ROY

Kim Chi

Nicholas Turner

Emmanuel Stylianos Antonarakis

Roland Matsouaka

Funda Meric-Bernstam

Andrew Nixon

Huiman Barnhart

Make your next move.